Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 17.11.2025Gedeon Richter Plc. (GDN)32501Protevasc 35 mg tablety s predĺženým uvoľňovaním (tbl plg 120x35 mg (blis.Al/PVC))26.11.2025R
 17.11.2025Gedeon Richter Plc. (GDN)09510Protevasc 35 mg tablety s predĺženým uvoľňovaním (tbl plg 60x35 mg (blis.Al/PVC))26.11.2025R
 17.11.2025Gedeon Richter Plc. (GDN)31552Ossica 3 mg injekčný roztok naplnený v injekčnej striekačke (sol iru 1x3 ml/3 mg (striek.inj.napln.) + 1x inj.ihla)25.11.2025R
 17.11.2025Zentiva, k.s. (ZNT-1)9823DKapidin 20 mg (tbl flm 30x20 mg (blis.Al/PVC/PVDC))19.11.2025O
 3.10.2025Teva B.V. (TEV-NL-4)8588BAtomoxetine Actavis 18 mg (cps dur 28x18 mg (blis.PVC/PVDC/PVC/Al))19.11.2025R
 17.11.2025Zentiva, k.s. (ZNT-1)31038Desloratadin Zentiva 5 mg filmom obalené tablety (tbl flm 50x5 mg (blis.PCTFE/PVC/Al))19.11.2025O
 17.11.2025Zentiva, k.s. (ZNT-1)31040Desloratadin Zentiva 5 mg filmom obalené tablety (tbl flm 100x5 mg (blis.PCTFE/PVC/Al))19.11.2025O
 18.11.2025Teva B.V. (TEV-NL-4)76402Sorbimon 20 mg (tbl 100x20 mg)18.11.2025R
 18.11.2025Teva B.V. (TEV-NL-4)47861Myfenax 500 mg filmom obalené tablety (tbl flm 50x500 mg (blis.PVC/PVDC/Al))18.11.2025R
 18.11.2025B.Braun Melsungen AG (BME)80181Gentamicin B. Braun 3 mg/ml infúzny roztok (sol inf 20x80 ml/240 mg (fľ. LDPE))18.11.2025R
 18.11.2025TEVA Pharmaceuticals Slovakia s.r.o. (TEV-SK)5784BNASAL DUO ACTIVE 0,5/50 mg/ml (aer nao 1x10 ml/90 dávok (fľ.HDPE s mech.rozpraš.))18.11.2025R
 18.11.2025Almirall Hermal GmbH (POS-D)60413Balneum Hermal Plus (add bal 1x500 ml (fľ.PVC))18.11.2025R
 18.11.2025B.Braun Melsungen AG (BME)33833Hydrogenuhličitan sodný B. Braun 4,2 % (sol inf 10x250 ml (fľ.skl.))18.11.2025R
 18.11.2025Almirall Hermal GmbH (POS-D)60405Balneum Hermal (add bal 1x500 ml (fľ.PVC))18.11.2025R
 17.11.2025Otsuka Pharmaceutical Netherlands B.V. (OTS-NL)8419AAbilify Maintena 400 mg prášok a disperzné prostredie na injekčnú suspenziu s predĺženým uvoľňovaním (plu igf 1x400 mg+1x2 ml+samost.bal.(liek.inj.skl.))17.11.2025O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)